| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Aspirin 325 mg and carisoprodol 200 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 325 mg and carisoprodol 200 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 325 mg and meprobamate 200 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 325 mg and meprobamate 200 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 325 mg and methocarbamol 400 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Aspirin 325 mg and methocarbamol 400 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 1 | 
| Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 1 | 
| Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Atenolol 100 mg and chlortalidone 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Atenolol 100 mg and chlortalidone 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Atenolol 50 mg and chlortalidone 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Atenolol 50 mg and chlortalidone 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| atovakvon 62,5 mg + proguanilhydroklorid 25 mg, tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 1 | 
| atovakvon 62,5 mg + proguanilhydroklorid 25 mg, tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| atropin 25 mikrogram och difenoxinhydroklorid 1 milligram, oral tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 1 | 
| atropin 25 mikrogram och difenoxinhydroklorid 1 milligram, oral tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 1 | 
| Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 3 | 
| Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 3 | 
| Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| bisoprolol 5 milligram och hydroklortiazid 6,25 milligram, oral tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 1 | 
| bisoprolol 5 milligram och hydroklortiazid 6,25 milligram, oral tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| karbidopa 10 mg + levodopa 100 mg, tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 1 | 
| karbidopa 10 mg + levodopa 100 mg, tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| karbidopa 25 mg + levodopa 100 mg, tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 1 | 
| karbidopa 25 mg + levodopa 100 mg, tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| karbidopa 25 mg + levodopa 250 mg, tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 1 | 
| karbidopa 25 mg + levodopa 250 mg, tablett | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Chlorothiazide 250 mg and methyldopa 250 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Chlorothiazide 250 mg and methyldopa 250 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Chlorothiazide 250 mg and reserpine 125 microgram oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Chlorothiazide 250 mg and reserpine 125 microgram oral tablet | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 | 
| Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 3 | 
| Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 2 | 
| Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | True | mg | Inferred relationship | Some | 1 | 
| Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | False | mg | Inferred relationship | Some | 2 |